Mana.bio
Highly Engaged Employees
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Hamelacha St, Tel Aviv-yafo, 6721502, ...Website
mana.bioRevenue
<$5 MillionIndustry
About Mana.bio
Mana.bio Org Chart
Is Mana.bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Mana.bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Mana.bio
Check if Mana.bio has recently received funding, and reach out quickly before it becomes old news!
Mana.bio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Mana.bio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Mana.bio has new funding data
Product Launch: Get notified when Mana.bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Mana.bio is spiking on competitors!
Recommended Actions
Find VP level buyers at Mana.bio
Find 3 more new buyers
Company Profile Activity
Activity Insights
Mana.bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mana.bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mana.bio.
Mana.bio financials insights
Gather financial insights about Mana.bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$19.5M
Mana.bio Tech Stack
A closer look at the technologies used by Mana.bio
Most Recent Scoops
Mana.bio News & Media
Mana.bio Unveils Mina™,The World's First Large Language Model-Powered AI Agent for Lipid Nanoparticles
BOSTON and TEL AVIV, Israel, Sept. 17, 2025 /PRNewswire/ -- Mana.bio, a biotechnology company pioneering the intersection of artificial intelligence and RNA delivery, today announced the launch of Mina™, the world's first large language model (LLM) built specifically for lipid...Mana.bio Presents New Data Demonstrating the Power of AI towards Unlocking the Potential of RNA Medicine
- New posters overview Mana.bio's machine learning (ML) architecture and demonstrate the platform's predictive capacity for lipid nanoparticle (LNP) safety and specificity – - New findings demonstrate specific achievements towards the development of precision RNA therapies targeting...Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model
Mana's lung-targeting AI model initially yielded a highly-specific, lung-tropic LNP Iterative in-silico / in-vitro cycles improved in-vivo potency by ~100X in 3-months Data seamlessly translated from cell culture to mice to primates ML-safety prediction model broadly improved tolerability...Sheba Medical Center, ARC & Mana.bio Announce Partnership to Revolutionize RNA Delivery for Cancer & Autoimmune Diseases
Collaboration harnesses advanced AI to enhance personalized medicine by using RNA delivery to reprogram T cells in the fight against challenging diseases TEL AVIV, ISRAEL, October 1, 2024 /EINPresswire.com/ -- Sheba Medical Center, Israel’s largest …
Top Business Services Companies
Frequently Asked Questions Regarding Mana.bio
Based out of Tel Aviv, Israel, Mana.bio provides an AI platform that discovers and optimizes novel, customizable LNPs for tissue-specific delivery of nucleic acid-based therapeutics and vaccines.... Read More
